Header Logo

Connection

Kelly Standifer to Receptors, Opioid, kappa

This is a "connection" page, showing publications Kelly Standifer has written about Receptors, Opioid, kappa.
Connection Strength

0.455
  1. Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells. Neurosci Lett. 2001 Feb 23; 299(3):173-6.
    View in: PubMed
    Score: 0.184
  2. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther. 1994 Sep; 270(3):1246-55.
    View in: PubMed
    Score: 0.118
  3. Characterizing kappa3 opioid receptors with a selective monoclonal antibody. Synapse. 1996 Mar; 22(3):247-52.
    View in: PubMed
    Score: 0.033
  4. Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J Neurochem. 1995 Jul; 65(1):170-5.
    View in: PubMed
    Score: 0.031
  5. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Mol Pharmacol. 1995 Jun; 47(6):1180-8.
    View in: PubMed
    Score: 0.031
  6. Opioid binding in giant toad and goldfish brain. Receptor. 1994; 4(1):55-62.
    View in: PubMed
    Score: 0.028
  7. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone. Mol Pharmacol. 1991 Mar; 39(3):290-8.
    View in: PubMed
    Score: 0.023
  8. TIPP[psi], a highly selective delta ligand. Neurosci Lett. 1994 Nov 07; 181(1-2):47-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.